ATM protein is deficient in over 40% of lung adenocarcinomas

Lung cancer is the leading cause of cancer-related mortality in the USA and worldwide, and of the estimated 1.2 million new cases of lung cancer diagnosed every year, over 30% are lung adenocarcinomas. The backbone of 1(st)-line systemic therapy in the metastatic setting, in the absence of an action...

Descripción completa

Detalles Bibliográficos
Autores principales: Villaruz, Liza C., Jones, Helen, Dacic, Sanja, Abberbock, Shira, Kurland, Brenda F., Stabile, Laura P., Siegfried, Jill M., Conrads, Thomas P., Smith, Neil R., O'Connor, Mark J., Pierce, Andrew J., Bakkenist, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295384/
https://www.ncbi.nlm.nih.gov/pubmed/27259260
http://dx.doi.org/10.18632/oncotarget.9757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295384/
https://www.ncbi.nlm.nih.gov/pubmed/27259260
http://dx.doi.org/10.18632/oncotarget.9757

Ejemplares similares